Bizarre Patents
A method for inducing cats to exercise consists of directing a beam of invisible light produced by a hand-held laser apparatus onto the floor or wall.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8003131 | Biomaterial derived from vertebrate liver tissue A tissue graft composition comprising liver basement membrane is described. The graft composition can be implanted to replace or induce the repair of damaged or diseased tissues. ... | 08/23/2011 |
| 7482025 | Biomaterial derived from vertebrate liver tissue A tissue graft composition comprising liver basement membrane is described. The graft composition can be implanted to replace or induce the repair of damaged or diseased tissues. ... | 01/27/2009 |
| 7202230 | Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity The present invention describes the use of polysaccharide derivatives for the preparation of biocompatible and biodegradable biomaterials with absorbent properties for body fluids and physical hemostatic activity, to be used in both venous and arterial vascular anas... | 04/10/2007 |
| 7189418 | Method for extracting lipid mixture containing phospholipids comprising polyunsaturated fatty acids from viscera of fish, method for preserving viscera prior to extraction, and lipid mixture extracted thereby The present invention provides a method for extracting a lipid mixture having a high percentage of phospholipids comprising polyunsaturated fatty acids. The method comprises the steps of (a) heating the viscera of fish with hot water or steam; and (b) extracting fro... | 03/13/2007 |
| 7168348 | Screwdriver bits The invention pertains to a screwdriver bit with a drive section (14) and a front section (1) that contains a profiled penetrating section (2) and is manufactured by compression molding and subsequently sintering a hard metal powder, where the f... | 01/30/2007 |
| 7139666 | Method for identifying or characterizing properties of polymeric units The invention relates to methods of identifying and characterizing properties of polymers to provide information about the polymer such as the charge of the polymer, the number and types or characteristics of units of the polymer and the sequence of the polymers. Th... | 11/21/2006 |
| 7056504 | Rationally designed heparinases derived from heparinase I and II Modified heparinases having altered binding specificity and activity are provided. Isolated nucleic acids encoding the same as well as vectors and host cells are provided. Methods for using the modified heparinases are also provided. ... | 06/06/2006 |
| 6947849 | Method for identifying or characterizing properties of polymeric units The invention relates to methods of identifying and characterizing properties of polymers to provide information about the polymer such as the charge of the polymer, the number and types or characteristics of units of the polymer and the sequence of the polymers. Th... | 09/20/2005 |
| 6911220 | Allogeneic and xenogeneic transplantation The invention provides methods for restoring or inducing immunocompetence, the methods including the step of introducing donor thymic tissue into the recipient. The invention also provides methods for inducing tolerance in a recipient including introducing donor thy... | 06/28/2005 |
| 6793939 | Biomaterial derived from vertebrate liver tissue A tissue graft composition comprising liver basement membrane is described. The graft composition can be implanted to replace or induce the repair of damaged or diseased tissues. ... | 09/21/2004 |
| 6696094 | Herbal pharmaceutical composition for treatment of HIV/AIDS patients The present invention provides a pharmaceutical composition for treating patients with HIV infection. The pharmaceutical composition is in the form of an intravenous injection solution and optionally capsules. The pharmaceutical composition contains fourt... | 02/24/2004 |
| 6652846 | Attractants for yellow jackets The invention relates to attractants for use in yellow jacket traps. The attractants have improved overall effectiveness in attracting yellow jackets, in attracting a broader spectrum of yellow jacket species and in attracting yellow jackets in the severa... | 11/25/2003 |
| 6379710 | Biomaterial derived from vertebrate liver tissue A tissue graft composition comprising liver basement membrane is described. The graft composition can be implanted to replace or induce the repair of damaged or diseased tissues.... | 04/30/2002 |
| 6350472 | Method of treating HIV infection with transdermal gel containing mammalian liver extract A method for treating human immuno-deficiency virus infection (HIV-1), comprising administering a therapeutically effective amount of a mammalian liver extract characterized by being heat stable, insoluble in acetone, and soluble in water. A transdermal c... | 02/26/2002 |
| 6294350 | Methods for treating fibroproliferative diseases In accordance with the present invention, fibroproliferative disease or condition characterized by such symptoms as increased levels of c-Jun homodimers, increased heterodimerization of c-Jun with another signaling peptide, increased levels of phosphoryla... | 09/25/2001 |
| 6255502 | Pharmaceutical composition containing acid addition salt of basic drug A pharmaceutical composition contains an acid addition salt of a basic drug and a fatty acid or bile acid. The acid addition salts thus formed exhibit enhanced transmucosal and transdermal penetration of the basic drug. The acid addition salts, an inclusi... | 07/03/2001 |
| 6207200 | Use of proteins as anti-retroviral agents The present invention relates to the discovery that a protein, having a molecular weight of about 14 Kd, extracted with perchloric acid from animal organs such as goat liver, has anti-retroviral activity, and may be used in the treatment of Human Immunode... | 03/27/2001 |
| 6165515 | Method for treatment of osteoporosis A therapeutic agent for osteoporosis brought about by a decrease in estrogen comprises an extract from inflammatory rabbit skin inoculated with vaccinia virus as an effective component. In ovariectomized rats, a model animal for osteoporosis brought about... | 12/26/2000 |
| 6156349 | Method of treating HIV infection with suppository containing mammalian liver extract A method for treating human immuno-deficiency virus infection (HIV-1), comprising administering a therapeutically effective amount of a mammalian liver extract characterized by being heat stable, insoluble in acetone, and soluble in water. A rectal suppos... | 12/05/2000 |
| 5985592 | Uses for pentoxifylline or functional derivatives/metabolites thereof In accordance with the present invention, it has been discovered that monocyte conditioned medium (MCM) obtained from patients with liver disease stimulates the proliferation of fibroblasts. Platelet derived growth factor (PDGF) has also been found to sti... | 11/16/1999 |
| 5922358 | Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications Heparin compositions having an antithrombotic activity and virtually no hemorrhagic activity are presented. The object of the invention is to eliminate the risk of bleeding associated with heparins while retaining their main properties. The compositions o... | 07/13/1999 |
| 5840342 | Shark liver extract for stimulating the immune system A water soluble, non-toxic, purified, biological preparation extracted from sharks liver which inhibits the growth of cancer cells by stimulating the patient's immune system and reduces toxic effects on patients exposed to radiation used to treat cancer. ... | 11/24/1998 |
| 5833979 | Methods and compositions of growth control for cells encapsulated within bioartificial organs This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth s... | 11/10/1998 |
| 5707657 | Food supplement containing animal fetal mesenchymal matter and animal fetal organ extracts A food supplement comprises isolated animal mesenchymal matter of fetal origin and extracts of animal organs of fetal origin, the mesenchymal matter consisting of a network of loose connective tissue and the food supplement being free of chemical preserva... | 01/13/1998 |
| 5639939 | Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue Xenogeneic tissue is introduced into an immunocompromised host for interacting with agents and using such interaction for evaluating efficacy of drugs and vaccines, producing xenogeneic monoclonal antibodies, evaluating the effect of the various agents on... | 06/17/1997 |
| 5625127 | Extended human hematopoiesis in a heterologous host A human hematopoietic system is provided in an immunocompromised mammalian host, where the hematopoietic system is functional for extended periods of time. Particularly, human fetal liver tissue and human fetal thymus is introduced into an appropriate sit... | 04/29/1997 |
| 5612018 | Drug screening and treatment for HIV thymocyte depletion A method is provided for screening compounds for the ability to supress thymocyte depletion in thymuses of HIV-infected individuals, particularly enhancing the CD4+ -expressing population as compared to an untreated individual. Particularly, dr... | 03/18/1997 |
| 5597913 | Glycogen polysaccharides Glycogen polysaccharides substantially free of nitrogenous compounds and reducing sugars.... | 01/28/1997 |
| 5476997 | Extended human hematopoiesis in a heterologous host A human hematopoietic system is provided in an immunocompromised mammalian host, where the hematopoietic system is functional for extended periods of time. Particularly, human fetal liver tissue and human fetal thymus is introduced into an appropriate sit... | 12/19/1995 |
| 5434341 | Xenogeneic lymph node in mammary fat pad Methods and chimeric immunocompromised hosts comprising functional xenogeneic organs are provided, particularly hematopoietic organs, where the xenogeneic organ is engrafted into a mammary fat pad. Exemplary is the engrafting of lymph node with mesenteric... | 07/18/1995 |
| 5393534 | Liver-derived tumor cell growth inhibitor A factor has been purified from rat liver homogenate which displays preferential growth inhibitory effects on non-liver metastasizing tumor cells. The purification steps include heat treatment, ammonium sulfate precipitation, anion exchange chromatography... | 02/28/1995 |
| 5334395 | Method of treating an epstein-barr viral infection A therapeutic method for treating Epstein-Barr virus infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in w... | 08/02/1994 |
| 5316775 | Method of treating hepatitis B infection A therapeutic method for treating hepatitis B infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, p... | 05/31/1994 |
| 5284664 | Method of treating the symptoms of Alzheimer's disease A therapeutic method for treating Alzheimer's or related disease. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in... | 02/08/1994 |
| 5268175 | Cosmetic and/or pharmaceutical compositions and methods for their use Topical cosmetic and pharmaceutical compositions are provided for the external protection of human or animal tissues from contact with heavy metals, and the composition includes a metal sequestering component capable of binding metal ions and a physiologi... | 12/07/1993 |
| 5238684 | Compositions and methods for achieving improved physiological response to exercise Disclosed here are novel compositions and methods which can be used as a blood substitute to ameliorate adverse physiological effects of blood loss. The novel compositions comprise fluids containing water, electrolytes, glycerol, and additional energy sou... | 08/24/1993 |
| 5057324 | Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof A physiologically active substance is extracted from infected tissues inoculated with a poxvirus. The novel substance of the present invention has inhibitory action against the formation of kallikrein, thus is useful as drugs such as antiinflammatory, ana... | 10/15/1991 |
| 5055296 | Method of treating chronic fatigue syndrome A therapeutic method for treating viral infections and chronic fatigue syndrome. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone... | 10/08/1991 |
| 5032400 | Shark liver oil and garlic oil topical analgesic Strains, sprains and sore skeletal muscles are treated with topical application of pharmaceutical composition containing a combination of shark liver oil and garlic oil in a cream or ointment base.... | 07/16/1991 |
| 4994374 | Diagnostic method of cirrhosis and hepatic cancer This invention relates to a method of diagnosing cancerous diseases, which comprises measuring the amount of UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminyl-transferase in body fluid and evaluating the increase in its amount for the diagnosis of... | 02/19/1991 |
